Agilent Technologies (A) Revenue by End Market

History

Date	Pharmaceutical and Biopharmaceutical	Chemicals and Advanced Materials	Diagnostics and Clinical	Environmental and Forensics	Food	Academia and Government
Mar 31, 2026	2.56B	1.60B	1.05B	679.00M	635.00M	533.00M
Dec 31, 2025	2.51B	1.56B	1.03B	674.00M	637.00M	540.00M
Sep 30, 2025	2.41B	1.53B	1.01B	658.00M	624.00M	554.00M
Jun 30, 2025	2.32B	1.49B	992.00M	663.00M	611.00M	550.00M
Mar 31, 2025	2.26B	1.48B	976.00M	656.00M	603.00M	554.00M
Dec 31, 2024	2.24B	1.50B	964.00M	650.00M	592.00M	567.00M
Sep 30, 2024	2.24B	1.49B	945.00M	661.00M	596.00M	567.00M
Jun 30, 2024	2.29B	1.51B	944.00M	657.00M	603.00M	585.00M
Mar 31, 2024	2.36B	1.53B	955.00M	662.00M	625.00M	605.00M
Dec 31, 2023	2.43B	1.54B	966.00M	662.00M	628.00M	601.00M
Sep 30, 2023	2.52B	1.59B	975.00M	665.00M	643.00M	601.00M
Jun 30, 2023	2.58B	1.60B	968.00M	663.00M	643.00M	594.00M
Mar 31, 2023	2.55B	1.55B	959.00M	665.00M	619.00M	581.00M
Dec 31, 2022	2.52B	1.52B	963.00M	656.00M	617.00M	576.00M
Sep 30, 2022	2.43B	1.45B	964.00M	638.00M	597.00M	579.00M
Jun 30, 2022	2.36B	1.40B	972.00M	629.00M	589.00M	578.00M
Mar 31, 2022	2.31B	1.37B	964.00M	630.00M	596.00M	575.00M
Dec 31, 2021	2.23B	1.33B	937.00M	652.00M	600.00M	576.00M
Sep 30, 2021	2.12B	1.29B	906.00M	653.00M	599.00M	574.00M
Jun 30, 2021	1.98B	1.22B	842.00M	641.00M	579.00M	555.00M

Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.